Halewood Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 3.30 M
as on 23-10-2024
- Company Age 24 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 183.83 Cr
as on 23-10-2024
- Satisfied Charges ₹ 22.84 Cr
as on 23-10-2024
- Revenue 9.01%
(FY 2023)
- Profit 15.54%
(FY 2023)
- Ebitda 23.69%
(FY 2023)
- Net Worth 42.33%
(FY 2023)
- Total Assets 40.53%
(FY 2023)
About Halewood Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.30 M.
The company currently has active open charges totaling ₹183.83 Cr. The company has closed loans amounting to ₹22.84 Cr, as per Ministry of Corporate Affairs (MCA) records.
Krutin Chaturvedi, Kaushik Chaturvedi, and Sanchit Chaturvedi serve as directors at the Company.
- CIN/LLPIN
U24231GJ2000PTC038236
- Company No.
038236
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jun 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Halewood Laboratories Private Limited offer?
Halewood Laboratories Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Anti Infective Drugs & Medicines, Anti Infective Agent, Cardiovascular Drugs & Medication, Diabetes Medicine, Common Disease Medicines, Injectable Products.
Who are the key members and board of directors at Halewood Laboratories?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krutin Chaturvedi  | Managing Director | 25-Sep-2014 | Current |
| Sanchit Chaturvedi | Managing Director | 22-Dec-2011 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kaushik Chaturvedi | Director | 20-Jun-2000 | Current |
Financial Performance of Halewood Laboratories.
Halewood Laboratories Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.01% increase. The company also saw a substantial improvement in profitability, with a 15.54% increase in profit. The company's net worth Soared by an impressive increase of 42.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Halewood Laboratories?
In 2023, Halewood Laboratories had a promoter holding of 81.08% and a public holding of 18.92%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Manage Your Health Technologies Private LimitedActive 9 years 2 months
Krutin Chaturvedi is a mutual person
Charges (Loans)
₹183.83 Cr
₹22.84 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 177.30 Cr
- Hdfc Bank Limited : 4.81 Cr
- Sidbi : 1.72 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Apr 2024 | Hdfc Bank Limited | ₹4.50 Cr | Open |
| 22 Mar 2023 | Hdfc Bank Limited | ₹0.79 M | Open |
| 22 Mar 2023 | Hdfc Bank Limited | ₹0.87 M | Open |
| 10 Nov 2021 | Axis Bank Limited | ₹82.50 Cr | Open |
| 03 Sep 2021 | Sidbi | ₹1.72 Cr | Open |
How Many Employees Work at Halewood Laboratories?
Halewood Laboratories has a workforce of 183 employees as of May 14, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Halewood Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Halewood Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
